Professional Documents
Culture Documents
net/publication/322650599
CITATIONS READS
56 882
4 authors, including:
Some of the authors of this publication are also working on these related projects:
Chemical modification of graphene oxide surface by D-Galactose to remove methylene blue pigment View project
All content following this page was uploaded by Hamed Hashemi on 10 June 2018.
DOI: 10.1002/adv.21938
RESEARCH ARTICLE
1
Research Laboratory of Dendrimers and
Nanopolymers, Faculty of Chemistry,
Abstract
University of Tabriz, Tabriz, Iran In this work, gelatin was chemically cross-linked using epichlorohydrin. Then, a se-
2
Research Center for Pharmaceutical ries of gelatin-based hydrogel nanocomposites containing CuO nanoparticles were
Nanotechnology (RCPN), Tabriz University prepared by immersion of gelatin hydrogel in CuCl2 solution with different concen-
of Medical Science, Tabriz, Iran
trations. Gelatin was chosen, due to its cheapness, nontoxicity, and biocompatibility.
Correspondence The structure and morphology of hydrogel nanocomposites were characterized by a
Hassan Namazi, Research Laboratory of
number of techniques such as FT-IR, XRD, energy dispersive X-ray spectroscopy,
Dendrimers and Nanopolymers, Faculty of
Chemistry, University of Tabriz, Tabriz, and scanning electron microscopy. Then, swelling behavior of synthesized hydrogel
Iran. nanocomposites in distilled water and different saline solutions was investigated.
Email: namazi@tabrizu.ac.ir
Their sensitivity to pH, biodegradability, and gel content was determined. Moreover,
Funding information
the water uptake and shrinking kinetics of hydrogel nanocomposites were evaluated.
University of Tabriz and Research Center
for Pharmaceutical Nanotechnology Finally, they were used as drug delivery agent, and the different concentrations effect
(RCPN); Tabriz University of Medical of CuO nanoparticles present within the hydrogel nanocomposites compared with
Science
neat hydrogel on mentioned tests was studied.
KEYWORDS
CuO nanoparticles, gelatin, hydrogel, nanocomposite
hydrogels. Moreover, owing to having a large number of from Merck (Darmstadt, Germany). Cephalexin was pur-
functional groups, it can be cross-linked easily.[25] Gelatin chased from Dana Co of Iran. Deionized water was used
hydrogels are used as biodegradable materials in the medi- throughout this work.
cal and pharmaceutical.[26–29] As a result of exhibiting poor
mechanical strength, there are some limitations in the use of
2.2 | Preparation of gelatin hydrogel
gelatin for producing hydrogels. The structure of gelatin needs
to be reinforced by some filler materials such as nanoparti-
2.2.1 | Hydrogel of Gelatin
cles. Incorporating of nanoparticles, as multifunctional cross-
linking agents, to gelatin-based hydrogel matrices causes the About 100 ml of distilled water was introduced into a beaker
formation of strong networks with improved mechanical and and heated to 40°C and then 20 g of gelatin added and stirred
thermal properties.[30,31] Nano-sized materials show signifi- vigorously until a homogeneous viscous mixture obtained.
cant properties compared to bulk ones, by reason of their high Afterward, 3 ml of epichlorohydrin as cross-linker was added
surface-to-volume ratio. Copper oxide nanoparticles because dropwise under continuous stirring until mixture homog-
of easy preparation and unique physical and chemical proper- enized. Subsequently, this mixture was placed in warm water
ties are of great interest.[32] Copper oxide nanoparticles have bath at 80°C for 1 hr to remove unreacted chemicals; the
been used in various fields such as electric and magnetic stor- obtained hydrogel was washed with distilled water several
age devices, as a catalyst and solar energy transformation.[33] times, and finally dried in an oven at 50°C for 24 hr. Figure 1
As the copper ions are colorful, so the stage of their bind- represents the block diagram of gelatin hydrogel preparation
ing and converting to copper oxide nanoparticles can be vi- (Figure 1).
sually seen. Formerly, copper oxide nanoparticles have been
applied for preparing different nanocomposites, for example,
2.3 | Preparation of hydrogel
carboxymethyl cellulose/CuO,[34] and polyurethane/CuO.[35]
nanocomposites
Over the past decades, natural polymers (biopolymers) have
frequently been used as raw materials for the design of effi-
2.3.1 | Gelatin/CuO nanocomposites were
cient drug delivery systems (DDS).[36,37] The aim of DDS was
prepared by the following procedure
to provide a drug within the body to carry out some specific
therapeutic purposes. Among the different drug delivery sys- About 7 g of dried gelatin hydrogel was immersed in a
tems, hydrogels have particular properties which let them be CuCl2 solution with different concentrations (0/005, 0/01,
used as ideal drug delivery systems.[3] Because they are simi- 0/02, and 0/03 M) for 24 hr. Then, to remove unreacted
lar to body’s tissues, they have high water content and rubbery
consistency. Furthermore, hydrogels provide the possibility of
using in both dry and swollen networks for drug loading and
releasing.[38] This work deals with the preparation of new hy-
drogel nanocomposites through the in situ formation of CuO
nanoparticles within swollen gelatin hydrogel. By incorporat-
ing of copper oxide nanoparticles into the gelatin hydrogel, we
were to study the swelling, biodegradability properties, and
drug release profile of the nanocomposite hydrogel compared
to the neat hydrogel. After characterization, their swelling be-
haviors were investigated in detail. The o bjective of this arti-
cle was to prove whether the synthesized hydrogels have the
potential for applying for drug delivery purposes. Cephalexin
has been chosen as a model drug, being loaded in the hydrogel
nanocomposites. In vitro tests of drug delivery in conditions
simulating the gastrointestinal tract were carried out.
2 | EX P ER IME N TA L
2.1 | Materials
Gelatin with a molecular weight of 30,000 was obtained from
Aldrich. Epichlorohydrin (EPH) (99.5%), CuCl2, NaOH,
LiCl, KCl, MgCl2, NaCl, AlCl3, and HCl were purchased F I G U R E 1 Block diagram for gelatin hydrogel preparation
BAKRAVI et al.
3
|
copper ions from the surface of the hydrogels, copper ion- respectively. The pH values were precisely controlled by a pH
loaded hydrogels were taken out and washed with distilled meter (consort/C533). Then, 0.1 g of each sample was used and
water. The washed hydrogels were poured in NaOH solu- the swelling capacity evaluated according to Equation (1).
tion (100 ml of 0/2 M) for 15 min, to convert copper ions
to CuO nanoparticles. The obtained hydrogel nanocompos-
2.8 | Gel Content measurement
ites were washed with distilled water and dried in an oven
at 50°C for 48 hr. In this work, hydrogel nanocomposites To determine the gel content values of hydrogel nanocompos-
were marked with C0, C1, C2, C3, and C4, indicating ites, 0.1 g of each sample in its dry state was poured in excess
CuCl2 with 0/00, 0/005, 0/01, 0/02, and 0/03 M concentra- distilled water at room temperature for 24 hr. Then, swol-
tions, respectively. len samples were taken out, dried in an oven at 50°C, and re-
weighted. Gel content (Gel%) was calculated by Equation (2).
2.4 | Characterization wf
Gel% = (2)
wi
The FT-IR spectra were obtained in KBr pellets using Bruker
Vector FT-IR spectrometer in the region of 400–4,000 cm−1. where wf and wi are final and initial weights of sam-
X-ray diffraction pattern was gotten using a Siemens diffrac- ples, respectively. Table 1 gives the results of gel content
tometer with Cu-Ka radiation at 35 kV in the scan rate of 1°/ determination.
min and scan range of 2ϴ from 2° to 70°. All of the analyzed
samples were in powdery form. The morphology of dried sam- 2.9 | Determination of the
ples and elemental analysis of the particles were taken using reswelling kinetics
scanning electron microscopy (SEM) (LEO 1430VP) operated
at 15 kV after coating the dried samples with gold and silver Water uptake (WU) is used to determine the reswelling ki-
films. netics of different hydrogel nanocomposites after drying. To
evaluate WU, the dried gels were soaked again in distilled
water at room temperature. At consecutive time intervals, the
2.5 | Equilibrium swelling measurement samples were taken out and after removing the excess solu-
tion on their surface, weighted. The WU values were deter-
To measure the equilibrium swelling (ES) of hydrogel na-
mined according to Equation (3).
nocomposites in aqueous media, 0.2 g of dry samples was
immersed in 150 ml of distilled water at room temperature wt − wd
WU = × 100 (3)
for 24 hr. After reaching their maximum swelling capac- ws − wd
ity, the hydrogel nanocomposites were taken out, dried, where wt, ws, and wd are the weights of the wet hydrogel at
and weighted. ES was calculated according to the equation time t, wet hydrogel at equilibrium swelling at room tempera-
below: ture and dried hydrogel, respectively.
w − wd
ES = s
wd (1)
2.10 | Determination of the
where wd and ws are the weights of the initial and swollen shrinking kinetics
samples, respectively.
Water retention is used to evaluate the deswelling kinetics of
hydrogels. Thus, the shrinking rate of a salt solution and water
2.6 | Swelling of different salt solutions retention of the hydrogel nanocomposites were studied as fol-
lows. Distilled water-swollen hydrogel nanocomposites were
According to the swelling measurement in aqueous media,
immersed in 0.1 M solution of NaCl. At consecutive time in-
absorption of the hydrogel nanocomposites was determined
tervals, the hydrogel nanocomposites were taken out and after
in 0.1 M solution of NaCl, MgCl2, AlCl3, LiCl, and KCl. The
removing the excess solution on their surface, weighted. The
swelling capacity of samples was studied in NaCl solution
WR values were determined according to Equation (4).
with different concentrations as well.
wt − wd
WR = × 100 (4)
2.7 | Absorbency at different pHs ws − wd
The effect of pH variations on swelling in the range of pH 2–12 T A B L E 1 Gel content values of gelatin hydrogel nanocomposites
was studied. Several solutions with acidic and basic pH values
Sample C0 C1 C2 C3 C4
were prepared. To achieve pH ≥ 6.0 and pH < 6.0, NaOH solu-
tion with pH 13.0 and HCl solution with pH 1.0 were diluted, Gel content (%) 94.11 88.5 92.3 97.5 99.2
|
4 BAKRAVI et al.
where wt, ws, and wd are same as Equation (3). added back to the solution. The results of drug release are
presented in Figures 13 and 14.
2.11 | Biodegradability measurement
To measure the biodegradability of hydrogel nanocompos-
3 | RESULTS AND DISCUSSION
ites, 0.5 g of each sample was poured in distilled water at
3.1 | Formation of gelatin hydrogel
room temperature. At certain days, samples were taken out,
dried in an oven at 50°C, and their loss weights were calcu- At first, it was tried to cross-link gelatin by physical cross-
lated. Equation (5) is used to calculate the biodegradability of linking agents, but the obtained hydrogel decomposed in
hydrogel nanocomposites. the stage of converting copper ions to copper oxide nano-
( ) particles (NPs) by NaOH, so the chemical cross-linking
wi − wf
Percent remaining = 1 − × 100 agent (epichlorohydrin) was employed. Gelatin has many
(5)
wi functional groups in its structure, so it can easily react with
where wi and wf are weights of initial and dried hydrogels, epichlorohydrin.[26] Epichlorohydrin has been widely used
respectively. in the preparation of different hydrogels for drug delivery
purposes.[1] Epichlorohydrin is toxic for prolonged high-
level oral consumption.[4] But as it is connected to gelatin
2.12 | Drug loading
from both sides by strong covalent bonds,[5] and the excess
In this work, cephalexin was used as a model drug. The drug of epichlorohydrin was removed by washing using distilled
loading was carried out by immersing the hydrogels in ce- water, no specific toxicity was expected. The formation
phalexin solution. Experimentally, 0.2 g of each sample was mechanism of gelatin hydrogel is presented in Scheme 1.
suspended in 50 ml of the drug solution (50 mg/50 ml of In this process, amine groups on the chain of gelatin can
distilled water) at 37°C for 48 hr. Then, drug-bearing hydro- react with epichlorohydrin from both sides to yield hydro-
gels were taken out, washed, and dried. The amount of drug gel (Scheme 1).
loaded by the hydrogels was determined using UV-Vis spec-
troscopy at 262 nm. The results of drug loading were evalu-
ated by Equation (6).
3.2 | In situ formation of CuO Nanoparticles
Scheme 2 presents the formation of copper oxide nanopar-
Amount of drug in beads
Drug loading (g/g) = (6) ticles in the swollen polymer network. A two-step process
Amount of beads
was applied to prepare copper oxide nanoparticles. In the
first step, gelatin hydrogel was soaked in CuCl2 solution with
different concentrations. Then, carbonyl, amine, and ani-
2.13 | In vitro drug release studies onic groups of the gelatin hydrogel bound the copper (Cu+2)
ions via electrostatic interactions.[39] Consequently, its color
The drug release behaviors of hydrogels were studied
changed from bright yellow (neat hydrogel) to blue. When
in pH 1.2 (gastric fluid) and pH 7.4 (intestinal fluid).
these hydrogels were suspended in the suitable basic agent
Experimentally, 0.2 g of the drug- bearing hydrogels
(NaOH solution), Cu+2 ions converted to copper oxide nano-
was immersed in 50 ml of the chosen release medium at
particles. This followed visually by a change in color from
37°C and under magnetic stirring (50 rpm). At appropri-
blue to green, denoting the formation of copper oxide nano-
ate time intervals, 5 ml of the solution was taken out, and
particles inside the gelatin matrix. This process was simple
the amount of cephalexin released from the hydrogels was
and economical, for did not need to heat or any other tools
determined using UV spectrophotometer at 262 nm. To
(Scheme 2).
release medium being constant, the measured sample was
S C H E M E 1 Formation mechanism of
gelatin hydrogel by epichlorohydrin
BAKRAVI et al.
5
|
S C H E M E 2 In situ formation of
copper oxide nanoparticles within gelatin
hydrogel
F I G U R E 2 FT-IR spectra of (a) neat hydrogel, (b) gelatin/copper F I G U R E 3 XRD pattern of gelatin/copper oxide hydrogel
oxide hydrogel nanocomposite nanocomposite
|
6 BAKRAVI et al.
(a)
(b)
(c)
F I G U R E 7 Effect of cation radius on swelling of gelatin F I G U R E 8 Effect of cation charge on swelling of gelatin
hydrogel nanocomposites hydrogel nanocomposites
a low value of 45%. Because strong intermolecular hydro- F I G U R E 1 2 Deswelling kinetics of gelatin hydrogel
gen bonding interactions occurred in C0 during the desicca- nanocomposites
tion process, the relaxation and expansion of the molecular
chains greatly decreased.[46] In the cases of C1 and C2, as a
result of having electrostatic repulsion between copper oxide
nanoparticle and the interfacial chain,[3] a network of the
hydrogels expanded and water uptake increased. But in C3
and C4, copper oxide nanoparticles acted as cross-linker, and
with reducing expansion of molecular chains, water uptake
decreased (Figure 11).
3.14 | Drug loading and release behavior F I G U R E 1 4 Drug release behavior of gelatin hydrogel
nanocomposites in pH 7.4
Generally, drugs are incorporated into hydrogels by physical
entrapment.[9] It was reported that there is a physical interac-
tion between cephalexin and gelatin.[9] The carboxylic acid
and amine groups in cephalexin are converted to carboxy-
late and ammonium groups, respectively, and consequently,
it will easily attract by oppositely charged gelatin backbone.
According to similar study about the drug loading efficiency
in functionalized gelatin, the drug encapsulation efficiency
was reported to be 64%.[49]
The drug release behavior was studied to prove the capabil-
ity of gelatin/copper oxide hydrogel nanocomposites as drug
carriers. According to the previous studies about the drug
release behavior of gelatin-g-poly(N-isopropylacrylamide),
it was proposed that drug release occurred in four steps: in
the first stage or initial burst release stage, high drug con- F I G U R E 1 5 Drug release behavior of gelatin hydrogel
centration released in the first 30 min, that is most probably nanocomposites in pH
due to the discharge of localized drug molecules on the car-
rier surface; in the second-stage effect of diffusion, the drug
concentration remains almost constant from 1 to 4 hr, and it of pH 1.2, because of having more swelling. So, there is a
is believed that the hydrophilic properties of gelatin allow hy- direct correlation between drug release and swelling. When
drogel to swell more that consequently facilitate more drug the hydrogels swell, a transition from dry (glassy) to the
diffusion due to a loose polymeric network;[50,51] in stage swollen (rubbery) state takes place, substantially increasing
three or the combined diffusion and degradation stage, the the mobility of drug molecules in their softened matrix and
biodegradation of hydrogel network increased the drug con- causing drug to release. So, mechanism for drug release is
centration. In the last stage, the effect of polymer degrada- swelling-controlled. In this mechanism, the rate of drug re-
tion, the level of drug concentration decreased slowly.[51] The lease depends on the rate of hydrogel swelling.[52–56] With
in vitro drug release behaviors of hydrogel nanocomposites increasing swelling, the penetration of water molecules into
were analyzed in pH 1.2 (gastric fluid) and pH 7.4 (intesti- the hydrogel network increased, resulted in breaking more
nal fluid). The degree of drug release from hydrogel nano- hydrogen bonding interactions between drug molecules and
composites as a function of time is plotted in Figure 14 (pH the hydrogel and releasing hydrophilic drug molecules into
7.4) and Figure 15 (pH 1.2). According to these figures, in the buffer medium (Figures 14 and 15).
the C1 and C2 samples, CuO nanoparticles expand the hy-
drogel network due to the existence of repulsion forces. as
the amount of water molecules increased the drug release 4 | CONCLUSIONS
increased. however, in the case of C3 and C4 samples, the
presence of attractive forces, shrank the hydrogel network. Novel gelatin-based hydrogel nanocomposites in the presence
indeed in the presence of few amounts of water molecules, of copper oxide nanoparticles were successfully prepared.
the drug release decreased. Also the amount of drug release Their swelling properties were studied in detail. Cephalexin
from hydrogel nanocomposites in pH 7.4 is more than that was used as a model drug, after loading its release behaviors
|
10 BAKRAVI et al.
in pH 1.2 (gastric fluid) and pH 7.4 (intestinal fluid) were [7] K. Pagonis, G. Bokias, Polym. Bull. 2007, 58, 289.
investigated. X- ray diffraction and EDX patterns proved [8] T. Inoue, G. Chen, K. Nakamae, A. S. Hoffman, Polym. Gels
the formation of copper oxide nanoparticles in the hydrogel Netw. 1998, 5, 561.
[9] Y. M. Mohan, P. K. Murthy, K. M. Raju, React. Funct. Polym.
network. SEM micrograph of the hydrogel nanocomposites
2005, 63, 11.
showed the existence of copper oxide nanoparticles with a [10] K. M. Raju, M. P. Raju, Y. M. Mohan, Polym. Int. 2003, 52, 768.
size range of 25–30 nm within the hydrogel matrix. Measured [11] G. R. Mahdavinia, S. B. Mousavi, F. Karimi, G. B. Marandi, H.
swelling in various salt solutions was less than in distilled Garabaghi, S. Shahabvand, Express Polym. Lett. 2009, 3, 279.
water induced by screening effects. With an increase in salt [12] Y. Chen, Y. F. Liu, H. L. Tang, H. M. Tan, Carbohyd. Polym.
concentration and cation charge and reduction in cation ra- 2010, 81, 365.
dius, swelling decreased. It was observed that at high acidic [13] H. Namazi, Y. T. Hamrahloo, Adv. Pharm. Bull. 2011, 1, 40.
[14] G. B. Marandi, N. Sharifnia, H. Hosseinzadeh, J. Appl. Polym.
and basic media, the swelling was low but between pH 4 and
Sci. 2006, 101, 2927.
10 and swelling was high and approximately constant. As the
[15] M. Yadollahi, H. Namazi, M. Aghazadeh, Int. J. Biol. Macromol.
concentration of CuO nanoparticles increased, more parts of 2015, 79, 269.
hydrogel was engaged with nanoparticles and consequently [16] H. Namazi, R. Rakhshaei, H. Hamishehkar, H. SamadiKafild, Int.
the gel content increased. The reswelling of hydrogels de- J. Biol. Macromol. 2016, 85, 327.
creased at high concentrations of copper oxide nanoparticles; [17] H. Namazi, Bioimpacts 2017, 7, 73.
consequently, the water uptake of dried C1 reached 90%, [18] M. Yadollahi, S. Farhoudian, H. Namazi, Int. J. Biol. Macromol.
whereas that of dried C0 exhibited a low value of 45%. The 2015, 79, 37.
[19] T. Zhang, Q. Cheng, D. Ye, C. Chang, Carbohyd. Polym. 2017,
water retention of hydrogels reduced from 95% for C4 to 60%
169, 139.
for C0; hence, with decreasing concentration of copper oxide [20] T. Zhang, T. Zuo, D. Hu, C. Chang, ACS Appl. Mater. Interfaces
nanoparticles, water retention decreased. The rate of biodeg- 2017, 9, 24230.
radability at higher concentrations of CuO nanoparticles was [21] W. Wang, A. Wang, Carbohyd. Polym. 2009, 77, 891.
low, thus gel strength of gelatin hydrogel improved. Finally, [22] B. D. Kevadiya, G. V. Joshi, H. M. Mody, H. C. Bajaj, Appl. Clay
the amount of drug release from hydrogel nanocomposites Sci. 2011, 52, 364.
in pH 7.4 was more than in pH 1.2, because of having more [23] G. B. Marandi, Z. P. Kermani, M. Kurdtabar, Polym. Plast.
swelling. Technol. Eng. 2013, 52, 310.
[24] M. Sirousazar, M. Kokabi, Z. M. Hassan, A. R. Bahramian, Sci.
Iranica 2011, 18, 780.
ACKNOWLEDGMENTS [25] J. Y. Lai, J. Mater. Sci. Mater. Med. 2010, 21, 1899.
[26] H. Okino, Y. Nakayama, M. Tanaka, T. Matsuda, J. Biomed.
This work was supported by the University of Tabriz and Mater. Res. 2002, 59, 233.
Research Center for Pharmaceutical Nanotechnology [27] G. Buhus, C. Peptu, M. Popa, J. Desbrieres, Cellul. Chem.
(RCPN), Tabriz University of Medical Science. We thank our Technol. 2009, 43, 141.
colleagues from the chemistry department of the University [28] Y. Huang, W. Xie, L. Chen, Zhonghua Yu Fang Yi Xue Za Zhi
of Tabriz who provided insight and expertise that greatly as- 2013, 47, 455.
sisted the research. [29] J. Maitra, V. K. Shukla, Am. J. Polym. Sci. 2014, 4, 25.
[30] M. A. Daniele, A. A. Adams, J. Naciri, S. H. North, F. S. Ligler,
Biomaterials 2014, 35, 1845.
ORCID [31] T. S. Anirudhan, A. M. Mohan, RSC Adv. 2014, 4, 12109.
[32] P. R. Reddy, K. Varaprasad, R. Sadiku, K. Ramam, G. V. Reddy,
Hassan Namazi http://orcid.org/0000-0002-1977-4677
K. M. Raju, N. S. Reddy, J. Inorg. Organomet. Polym Mater.
2013, 23, 1054.
[33] J. Y. Lai, Y. T. Li, Biomacromol 2010, 11, 1387.
R E F E R E NC E S
[34] G. B. Marandi, H. Hosseinzadeh, Polym. Polym. Compos. 2007, 15, 395.
[1] E.T. Tenorio-Neto, de Souza Lima D., M. R. Guilherme, M. K. [35] F. M. Fernandes, A. I. Ruiz, M. Darder, P. Aranda, E. Ruiz-Hitzy,
Lima-Tenorio, D. B. Scariot, C. V. Nakamura, M. H. Kunita, A. J. Nanosci. Nanotechnol. 2009, 9, 221.
F. Rubira, RSC Adv. 2017, 7, 27637. [36] M. Suleiman, M. Mousa, A. Hussein, B. Hammouti, T. B. Hadda,
[2] M. Yadollahi, I. Gholamali, H. Namazi, M. Aghazadeh, Int. J. I. Warad, J. Mater. Environ. Sci. 2013, 4, 792.
Biol. Macromol. 2015, 74, 136. [37] A. S. Lanje, S. J. Sharma, R. B. Pode, R. S. Ningthoujam, Adv.
[3] M. Yadollahi, I. Gholamali, H. Namazi, M. Aghazadeh, Int. J. Appl. Sci. Res. 2010, 1, 36.
Biol. Macromol. 2015, 73, 109. [38] Z. Ahmad, M. A. Vargas-Reus, R. Bakhshi, F. Ryan, G. G. Ren, F.
[4] W. L. Hom, S. R. Bhatia, Polymer 2017, 109, 170. Oktar, R. P. Allaker, Methods Enzymol. 2012, 509, 87.
[5] V. H. G. Phan, T. Thambi, M. S. Gil, D. S. Lee, Polymer 2017, [39] S. Barkhordari, M. Yadollahi, H. Namazi, J. Polym. Res. 2014,
109, 138. 21, 1.
[6] S. Barkhordari, M. Yadollahi, H. Namazi, J. Polym. Res. 2014, [40] M. Hamidi, A. Azadi, P. Rafiei, Adv. Drug Deliv. Rev. 2008, 60,
21, 454. 1638.
BAKRAVI et al.
11
|
[41] R. Daganl, Chem. Eng. News 1997, 75, 26. [52] W. A. Laftah, S. Hashim, A. N. Ibrahim, Polym. Plast. Technol.
[42] M. Helminger, B. Wu, T. Kollman, D. Benke, D. Schwahn, V. Eng. 2011, 50, 1475.
Pipich, D. Faivre, D. Zahn, H. Colfen, Adv. Funct. Mater. 2014, [53] C. Chang, B. Duan, J. Cai, L. Zhang, Eur. Polym. J. 2010, 46, 92.
24, 3187. [54] E. van den Bosch, C. Gielens, Int. J. Biol. Macromol. 2003, 32,
[43] G. Buhus, C. Peptu, M. Popa, J. Desbrieres, Cellul. Chem. 129.
Technol. 2009, 43, 141. [55] P. R. Ninawe, S. J. Parulekar, Biotechnol. Prog. 2011, 27, 1442.
[44] S. F. Shaffiey, M. Shapoori, A. Bozorgnia, M. Ahmadi, Nanomed. [56] C. C. Lin, A. T. Metters, Adv. Drug Deliv. Rev. 2006, 58, 1379.
J. 2014, 1, 198.
[45] G. B. Marandi, G. B. Rouzbahani, M. Kurdtabar, J. Appl. Chem.
Res. 2014, 8, 63. How to cite this article: Bakravi A, Ahamadian Y,
[46] T. Hanemann, D. V. Szabó, Materials 2010, 3, 3468. Hashemi H, Namazi H. Synthesis of gelatin-based
[47] T. Hanemann, D. V. Szabo, Materials 2010, 3, 3468. biodegradable hydrogel nanocomposite and their
[48] A. I. Raafat, J. Appl. Polym. Sci. 2010, 118, 2642.
application as drug delivery agent. Adv Polym
[49] L.-J. Luo, J.-Y. Lai, Sci. Rep. 2017, 7, 9380.
[50] S.-F. Chou, L.-J. Luo, J.-Y. Lai, Acta Biomater. 2016, 38, 116.
Technol. 2018;00:1–11.
[51] G. Pass, G. O. Philips, D. J. Wedlock, Macromolecules 1977, 10, https://doi.org/10.1002/adv.21938
197.